Skip to main content
Log in

Prognostic factors in medullary thyroid carcinoma: evaluation of 741 patients from the German Medullary Thyroid Carcinoma Register

  • Original Articles
  • Published:
The clinical investigator Aims and scope Submit manuscript

Summary

A retrospective study of 741 patients with medullary thyroid carcinoma diagnosed between 1967 and 1991 was carried out by members of the German Medullary Thyroid Carcinoma Study Group to evaluate prognostic factors. A total of 559 patients (75%) were considered to have sporadic disease, and 182 (25%) had the familial type. The sex ratio (male to female) was 1:1.4 in sporadic disease patients, and the mean age at diagnosis was 45.9 years (range 5-81 years). For familial disease patients the sex ratio was 1:1.1, and the mean age at diagnosis was 33.4 (range 5–77 years). The follow-up time for 630 patients ranged from 1 month to 20.8 years (mean 13.0 years). The overall adjusted survival rate was 86.7% at 5 years and 64.2% at 10 years. In a univariate analysis the stage of disease at diagnosis, age, sex, and type of disease (sporadic, familial) were relevant prognostic factors, with a better prognosis for young female patients with familial disease and diagnosed at an early stage. In a multivariate proportional hazards analysis, the difference in the survival rate of patients with familial disease versus those with the sporadic form disappeared, while prognostic information provided by age and sex was still significant. The poorer prognosis of patients with sporadic medullary thyroid carcinoma may be related to the patients' older age at detection and more advanced tumor stage at diagnosis. There seems to be no difference in biological behavior between tumors of the sporadic and those of the familial type.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

MTC:

medullary thyroid carcinoma

MEN:

multiple endocrine neoplasia

CT:

calcitonin

References

  1. Bergholm U, Adami HO, Bergström R, Johannsson H, Lundell G, Telenius-Berg M, Ackerström G (1989) Clinical characteristics in sporadic and familial medulläre thyroid carcinoma: a nationwide study of 249 patients in Sweden from 1959 through 1981. Cancer 63:1196–1204

    Google Scholar 

  2. Bergholm U, Adami HO, Bergström R, Bäckdahl M, Ackerström G (1990) Long-term survival in sporadic and familial medulläre thyroid carcinoma with special reference to clinical characteristic as prognostic factors. Acta Chir Scand 156:37–46

    Google Scholar 

  3. Calmettes C, Chaventre A, Feingold N, Franc B, Guliana JM(1989) Screening for medulläre thyroid cancer in France: a national effort. Henry Ford Hosp Med J 37:120–121

    Google Scholar 

  4. Chong GC, Beahrs OH, Sizemore GW, Woolner LH (1975) Medullary carcinoma of the thyroid gland. Cancer 35:695–704

    Google Scholar 

  5. Farndon JR, Leight GS, Dilley WG, Baylin SB, Smallridge RC, Harrison TS, Wells SA (1986) Familial medulläre thyroid carcinoma without associated endocrinopathies: a distinct clinical entity. Br J Surg 73:278–281

    Google Scholar 

  6. Fletcher JR (1970) Medullary (solid) carcinoma of the thyroid gland. Arch Surg 100:257–262

    Google Scholar 

  7. Frank K, Raue F, Gottswinter J, Heinrich H, Meybier H, Ziegler R (1984) Importance of early diagnosis and follow up in multiple endocrine neoplasia (MEN IIb). Eur J Pediatr 143:112–116

    Google Scholar 

  8. Gordon PR, Huvas AG, Strong EW (1973) Medullary carcinoma of the thyroid gland. Cancer 31:915–924

    Google Scholar 

  9. Grauer A, Raue F, GagelRF (1990) Changing concepts in the management of hereditary and sporadic medulläre thyroid carcinoma. Endocrinol Metab Clin North Am 19:613–635

    Google Scholar 

  10. Hazard JB, Hawk WA, Crile G (1959) Medullary (solid) carcinoma of the thyroid — a clinicopathologic entity. J Clin Endocrinol Metab 19:152–161

    Google Scholar 

  11. Hill CS, Ibanez ML, Samaan NA, Ahearn MJ, Carlk RL (1973) Medullary (solid) carcinoma of the thyroid gland. An analysis of the M.D. Anderson Hospital experience with patients with the tumor, its special feature, and its histogenesis. Medicine 52:141–171

    Google Scholar 

  12. Jackson CE, Talpos GB, Kambouris A, You JB, Tashjian AH, Block MA (1983) The clinical course after definitive operation for medulläre thyroid carcinoma. Surgery 94:995–999

    Google Scholar 

  13. Kakuda K, Carney A, Sizemore GW (1985) Medullary thyroid carcinoma of the thyroid: biological behavior of the sporadic and familial neoplasm. Cancer 55:2818–2821

    Google Scholar 

  14. Normann T, Gautvik KM, Johannessen JV, Brennhovd IO (1976) Medullary carcinoma of the thyroid in Norway. Acta Endocrinol 83:71–85

    Google Scholar 

  15. Ponder BAJ, Finer N, Coffey R, Harmer CL, Maisey M, Ormerod MG, Pembrey ME, Ponder MA, Rossick P, Shalet S (1988) Family screening in medulläre thyroid carcinoma patients presenting without a family history. Oncol J Med 67:299–308

    Google Scholar 

  16. Raue F, Späth-Röger M, Winter J, Benker G, Buhr P, Dorn R, Dralle H, Frilling A, Herrmann J, Hörnig I, Meybier H, Klempa I, Kotzerke J, Pfannenstiel P, Reinwein D, Ritter M, Röher HD, Schober O, Schröder S, Seif F, Trede M, Vogt H, Wahl R, Ziegler R (1990) Register für das medulläre Schilddrüsencarcinom in der Bundesrepublik Deutschland. Med Klin 85:113–117

    Google Scholar 

  17. Rougier P, Parmentier C, Laplanche A, Lefevre M, Travagli JP, Caillou B, Schlumberger M, Lacour J, Tubiana M (1983) Medullary thyroid carcinoma: prognostic factors and treatment. Int J Radiat Oncol Biol Phys 9:161–169

    Google Scholar 

  18. Rossi RL, Cady B, Meissner WA, Wool MS, Sedgewick CE, Werber J (1980) Nonfamilial medulläre thyroid carcinoma. Am J Surg 139:554–559

    Google Scholar 

  19. Saad MF, Guido JJ, Samaan NA (1983) Radioactive iodine in the treatment of medulläre carcinoma of the thyroid. J Clin Endocrinol Metab 57:124–128

    Google Scholar 

  20. Saad MF, Ordonez NG, Rashid RK, Guido JJ, Hill CS, Hickey RC, Samaan NA (1984) Medullary carcinoma of the thyroid: a study of the clinical feature and prognostic factors in 161 patients. Medicine 63:319–342

    Google Scholar 

  21. Samaan GA, Schultz PN, Hickey RC (1988) Medullary thyroid carcinoma: Prognosis of familial versus sporadic disease and the role of radiotherapy. J Clin Endocrinol Metab 67:801–805

    Google Scholar 

  22. Schröder S, Böcker W, Baisch H, Bürk CG, Arps H, Meiners I, Kastendieck H, Heitz PU, Klöppel G (1988) Prognostic factors in medulläre thyroid carcinomas: survival in relation to age, sex, stage, history, immunocytochemistry, and DNA content. Cancer 61:806–816

    Google Scholar 

  23. Simpson WJ, Palmer JA, Rosen IB, Mustard RA (1982) Management of medulläre carcinoma of the thyroid. Am J Surg 144:420–422

    Google Scholar 

  24. Sizemore GW (1987) Medullary carcinoma of the thyroid gland. Semin Oncol 14:306–314

    Google Scholar 

  25. Spiessl B, Hermanek P, Scheibe O, Wagner G (1988) UICC: TNM-Atlas, Illustrierter Leitfaden zur TNM/pTNM-Klassifikation maligner Tumoren, 3rd edn. Springer, Berlin Heidelberg New York

    Google Scholar 

  26. Vasen HFA, Nieuwenhuijzen AC, Moers AMJ, Lips CJM, Benkers EKM, Wiersinga WM, Geedink RA (1987) MEN2-A syndrome: the value of screening and central registration; a study of six kindreds in the Netherlands. Henry Ford Hosp Med J 35:101–103

    Google Scholar 

  27. Woolner LB, Beahrs OH, Black BM, McConahey WM, Keating RF (1961) Classification and prognosis of thyroid carcinoma. Am J Surg 102:354–387

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Additional information

See Appendix

Rights and permissions

Reprints and permissions

About this article

Cite this article

Raue, F., Kotzerke, J., Reinwein, D. et al. Prognostic factors in medullary thyroid carcinoma: evaluation of 741 patients from the German Medullary Thyroid Carcinoma Register. Clin Investig 71, 7–12 (1993). https://doi.org/10.1007/BF00210956

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00210956

Key words

Navigation